| abstract |
This invention provides a method for treating, preventing, suppressing, inhibiting, or reducing the risk of developing a bone-related disorder, for example osteoporosis, osteopenia, increased bone resorption, bone fracture, bone fragility and / or loss of bone mineral density ( BMD), when administering a therapeutically effective amount of a selective androgen receptor modulator (MRSA) and / or its analogue, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, or any combination of same. The invention also provides methods for reducing fat mass (FM) and increasing lean mass, comprising administering them. |